Sarepta Therapeutics, Inc.
SRPTNasdaqCIK 873303HealthcareFiscal year ends Dec 31
Reports and events: 348 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-03-0307:31 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-23-058990 |
| 2023-02-2816:04 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-005062 |
| 2023-01-0913:40 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-000495 |
| 2022-12-1317:11 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-22-303900 |
| 2022-11-0217:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-22-275897 |
| 2022-11-0216:04 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-021213 |
| 2022-09-1916:31 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-247130 |
| 2022-08-0216:03 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000950170-22-013863 |
| 2022-06-0316:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-22-011164 |
| 2022-05-0416:05 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0000950170-22-007375 |
| 2022-04-2516:19 ET | DEF 14A | Proxy statementPeriod 2022-06-02 | 0001564590-22-015429 |
| 2022-04-2108:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-22-112139 |
| 2022-04-0520:26 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-22-005381 |
| 2022-03-0116:03 ET | 10-K | Annual reportPeriod 2021-12-31 | 0000950170-22-002517 |
| 2022-01-1010:53 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-22-000205 |
| 2021-11-1708:34 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-21-004713 |
| 2021-11-0316:04 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0000950170-21-002815 |
| 2021-10-1516:17 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-300047 |
| 2021-09-2708:34 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-048961 |
| 2021-08-0416:03 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001564590-21-040787 |
| 2021-06-0317:00 ET | 8-K | 5.07 Shareholder vote results | 0001564590-21-031601 |
| 2021-05-1808:57 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-028550 |
| 2021-05-0516:02 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001564590-21-024018 |
| 2021-05-0308:52 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-022707 |
| 2021-04-2016:10 ET | DEF 14A | Proxy statementPeriod 2021-06-03 | 0001564590-21-019631 |
| 2021-03-0116:02 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001564590-21-009835 |
| 2021-01-1110:32 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-000783 |
| 2021-01-0717:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-000577 |
| 2020-12-1408:55 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001564590-20-056951 |
| 2020-11-0516:09 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001564590-20-051308 |
| 2020-09-2517:06 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001564590-20-044684 |
| 2020-09-0917:22 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-20-043013 |
| 2020-08-0516:06 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001564590-20-036794 |
| 2020-08-0516:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001564590-20-036775 |
| 2020-06-3008:40 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001564590-20-031151 |
| 2020-06-0809:18 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001564590-20-028562 |
| 2020-06-0809:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-20-028560 |
| 2020-05-0616:02 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001564590-20-021905 |
| 2020-04-2116:19 ET | DEF 14A | Proxy statementPeriod 2020-06-04 | 0001564590-20-017698 |
| 2020-03-1916:28 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001564590-20-011806 |
| 2020-02-2616:04 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001564590-20-006769 |
| 2020-02-2116:38 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001564590-20-005773 |
| 2020-02-1808:30 ET | 8-K | 8.01 Other events | 0001564590-20-004916 |
| 2020-01-1312:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-20-000941 |
| 2020-01-1308:41 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001564590-20-000918 |
| 2019-12-2316:01 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity | 0001564590-19-046705 |
| 2019-12-1316:01 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events | 0001564590-19-045957 |
| 2019-11-0716:03 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0001564590-19-041709 |
| 2019-10-0408:40 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-19-036441 |
| 2019-08-2018:29 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-19-032588 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 19:58 ET. Listed shows no prices and gives no investment advice.